Akèy › Kansè tete negatif triple › Connecticut
Etid klinik pou Kansè tete negatif triple nan Connecticut
19 etid pou Kansè tete negatif triple ap chèche patisipan nan sit nan Connecticut.
Vil nan Connecticut
Tèks ofisyèl etid la (Anglè)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Yale Cancer Center, New Haven
Ap rekriteFaz 1/2
Laj 12 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT04585750Study of AVZO-021 in Patients With Advanced Solid Tumors
- Avenzo Therapeutics Recruiting Site, New Haven
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT05867251Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
- University of Connecticut Health Center ( Site 0128), Farmington
- Yale Cancer Center ( Site 0053), New Haven
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06393374Lifestyle, Exercise, And Nutrition (LEAN) Trial on Pathologic Complete Response in TNBC
- Yale University, New Haven
Ap rekrite
Laj 18 ak plis · Fanm · Mizajou Sep 25, 2026 · NCT07066189A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
- Kivu Trial Site, New Have
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT07229313Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Yale University, Yale Cancer Center, New Haven
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05983432Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
- Yale Cancer Center Clinical Trials Office, New Haven
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07340541First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
- Yale Cancer Center, New Haven
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT06657222Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
- Stamford Hospital, Stamford
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT05633654A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
- Yale Cancer Center, New Haven
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT07029399A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Normunity Investigational Site, New Haven
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT07182149BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
- Yale New Haven Hospital, New Haven
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jun 15, 2026 · NCT05768932Saci Nivo Rela for TNBC
- Yale University, New Haven
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou May 22, 2026 · NCT06963905I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
- Yale Cancer Center, New Haven
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2026 · NCT01042379Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
- Stamford Hospital, Stamford
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Apr 29, 2026 · NCT04468061Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
- Hartford Healthcare, Hartford
- WCHN Norwalk Hospital - Data Collection, Norwalk
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Feb 27, 2026 · NCT03808337Food for Thought - A Nutrition Intervention for Women Undergoing Active Treatment for Triple Negative Breast Cancer
- Yale University, New Haven
Ap rekrite
Laj 40 a 65 · Fanm · Mizajou Dec 11, 2025 · NCT06582615A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
- Yale Cancer Center, New Haven
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Nov 4, 2025 · NCT05902988Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
- Yale Cancer Center, New Haven
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Nov 15, 2024 · NCT04787042Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.